Risk factors of hospitalization and readmission of patients with COPD exacerbation – systematic review by Bahadori, Katayoon & FitzGerald, J Mark
© 2007 Dove Medical Press Limited.   All rights reserved
International Journal of COPD 2007:2(3) 241–251 241
REVIEW
Risk factors of hospitalization and readmission 
of patients with COPD exacerbation – systematic 
review
Katayoon Bahadori1
J Mark FitzGerald1, 2
1Centre for Clinical Epidemiology and 
Evaluation, Vancouver Coastal Health 
Research Institute, Vancouver, British 
Columbia, Canada
2The Lung Centre, Vancouver 
General Hospital and University of 
British Columbia, Vancouver, British 
Columbia, Canada
Correspondence: J Mark FitzGerald
Centre for Clinical Epidemiology and 
Evaluation, VGH Research Pavilion, 
Vancouver General Hospital, 828 West 
10th   Avenue, Vancouver, BC V5Z 3J5, 
Canada
Tel +1 604 875 4122
Fax +1 604 875 4595
Email markf@interchange.ubc.ca
Background: Chronic obstructive lung disease (COPD) exacerbations are a signiﬁ  cant cause of 
morbidity and mortality. Data regarding factors which causes or prevents exacerbations is very 
limited. The aim of this systematic review is to summarize the results from available studies 
to identify potential risk factors for hospital admission and/or re-admission among patients 
experiencing COPD exacerbations.
Methods: We undertook a systematic review of the literature. Potential studies were identiﬁ  ed 
by searching the electronic databases: PubMed, EMBASE, BIOSIS, CINAHL, PsycINFO, 
Cochrane library, reference lists in trial reports, and other relevant articles.
Results: Seventeen articles that met the predeﬁ  ned inclusion criteria were identiﬁ  ed. Heteroge-
neity of study designs, risk factors and outcomes restrict the result to only a systematic review 
and precluded a formal meta-analysis. In this review, three predictive factors: previous hospital 
admission, dyspnea and oral corticosteroids were all found to be signiﬁ  cant risk factors of read-
missions and variables including using long term oxygen therapy, having low health status or 
poor health related quality of life and not having routine physical activity were all associated 
with an increased risk of both admission and readmission to hospital.
Conclusions: There are a number of potential modiﬁ  able factors that are independently 
associated with a higher risk of COPD exacerbation requiring admission/readmission to the 
hospital. Identifying these factors and the development of targeted interventions could potentially 
reduce the number and severity of such exacerbations.
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Introduction
A systematic review and critical appraisal provides an unbiased and comprehensive 
synthesis of the best available scientiﬁ  c evidence related to a clinical issue of interest 
(Slavin 1995; Murlow et al 1998).  Findings from a systematic review provide clinicians 
with an opportunity to examine this clinical evidence and its potential utility in the 
management of their own patients (Moher et al 1999).
Chronic obstructive pulmonary disease (COPD) is a term referring to a group of 
lung diseases characterized by ﬁ  xed airﬂ  ow obstruction.  Exacerbations of COPD are 
associated with considerable physiologic deterioration and increased airway inﬂ  amma-
tory changes that are caused by various factors such as viruses, bacteria, and possibly 
common pollutants.
Exacerbations of chronic obstructive pulmonary disease are now recognized to 
be an important cause of the considerable morbidity and mortality associated with 
COPD (Fletcher et al 1976).
Acute exacerbations are a common reason for hospital admissions and affects 
health-related quality of life (HRQL) (Seemungal et al 1998), and prognosis (Mannino International Journal of COPD 2007:2(3) 242
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2002). Its burden to society, as expressed in disability life 
years (DALYs), was ranked as eighth for men and seventh 
for women in 1996. It is predicted to rise to the ﬁ  fth leading 
cause worldwide for both sexes by 2020 (Murray and Lopez 
1997). A small proportion of COPD patients, approximately 
10%, experiencing acute exacerbations, accounts for over 
70 percent of costs as a result of COPD due to emergency 
visits and hospitalizations (Oostenbrink and Rutten-van 
Molken 2004).
Identifying risk factors for hospitalization and re-admission 
have important health policy implications, but the knowledge 
of which factor causes or prevents exacerbation is very lim-
ited. The reasons for readmission and, more importantly, how 
readmissions can be prevented, are not clear.
Some potential factors for COPD exacerbations have been 
studied.The aim of this systematic review is to summarize the 
results from available studies to identify potential risk factors 
for hospital admission and or re-admission among patients 
experiencing COPD exacerbations. This maybe helpful in 
allowing us identify intervention strategies.
Materials and methods
Search strategy
The databases used for the selection of the literature were 
Medline (1966 to Oct 2006), Embase (1988 to Oct 2006), 
CINAHL, BIOSIS, PsycINFO and the Cochrane library. We 
did not restrict the search to COPD patients with exacerba-
tion since exacerbation is not indexed as a Medical Subject 
Heading term (MeSH) for we feared that this could result in 
a narrow search and we may miss out relevant studies.
We used a broad search strategy using the terms “lung dis-
eases obstructive”, “chronic obstructive lung disease”, “chronic 
obstructive pulmonary disease”, “COPD exacerbation”, “bron-
chitis”, “emphysema”, “risk factors”, “hospitalization” and 
“readmission”. We added other terms: “smoking”, “LTOT”, 
“physical activity” and “early therapy” to capture more studies. 
The electronic searches were supplemented by scanning the ref-
erence lists from retrieved articles to identify additional studies 
that may have been missed during the initial search.
Study selection
Cohort, retrospective and prospective, cross-sectional and 
case-control studies were included. We related the citation list 
to patients with COPD and COPD exacerbation by excluding 
articles with titles and/or abstracts indicating patients with 
COPD associated with other concomitant heart/lung disease. 
Our focus was on studies that analyzed the contribution of risk 
factors for exacerbation of COPD leading to admission and re-
admission to hospital. Limiting our search to English language 
publications further reduced the list. Studies were selected for 
inclusion in the review according to deﬁ  nition for exacerbation 
of COPD, and admission/readmission. Two members of the 
review team independently scrutinized the titles and abstracts 
of all identiﬁ  ed citations and ordered the full text of any article 
that was deemed potentially eligible by one of the reviewers. 
The two reviewers evaluated the full text of all retrieved papers, 
made a decision on inclusion or exclusion and discussed the 
decisions. Any disagreement was resolved by consensus with 
close attention to the inclusion/exclusion criteria.
Data extraction and quality assessment
We selected studies that included COPD exacerbations and 
the risk factors leading to admission/readmission to hospital. 
We independently extracted data from the included studies 
and resolved any differences by discussion. We used a 
quality scoring system to reduce the effects of confounding 
often encountered in retrospective and observational studies. 
We arbitrarily assigned 2 points for each fulﬁ  lled criterion 
(maximum, 10 points). We selected the median score of all 
the articles as a cutoff point to categorize good and poor 
quality studies. Authors met to compare assigned scores, 
and discrepancies were resolved by discussion.
Results
Results of searches for documents
Our primary search yielded more than 1500 articles. 
Reviewing titles and abstracts, 79 articles possibly fulﬁ  lled 
the inclusion criteria. Among them, 17 articles met the criteria 
and have been reviewed for this study (Kessler et al 1999; 
Garcia-Aymerich et al (2000, 2001, 2003); Miravitlles et al 
(2000, 2006); Pouw et al 2000;  Lau et al 2001; Bourbeau 
et al 2003; Groenewegen et al 2003; Wilkinson et al 2004;   
Gadoury et al 2005; Gudmundsson et al 2005; Soler-Cataluña 
et al 2005; (Wang and Bourbeau 2005); Cao et al 2006; Con-
nolly et al 2006). The most common reason for exclusion was 
that it did not study “exacerbations” of COPD.
Study characteristics
Of the seventeen epidemiological studies, nine were cohorts 
(Kessler et al 1999; Lau et al 2001; Garcia-Aymerich et al 2003; 
Groenewegen et al 2003; Wilkinson et al 2004; Soler-Cataluña 
et al 2005; Wang et al 2005; Gudmundsson et al 2005; Connolly 
et al 2006), four were cross-sectional studies (Garcia-Aymerich 
et al 2000; Miravitlles et al (2000, 2006); Cao et al 2006), three 
were case-controls ( Pouw et al 2000;  Garcia-Aymerich et al 
2001; Bourbeau et al 2003) and one was a randomized clinical International Journal of COPD 2007:2(3) 243
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trial (Gadoury et al 2005). Seventy one percent were conducted 
in Europe, of these, 50% were from Spain. Three of the studies 
were conducted in Canada (Bourbeau et al 2003; Gadoury et al 
2005 and Wang et al 2005).
The study characteristics and demographic of the partici-
pants of the included studies are shown in Tables 1 and 2.
Heterogeneity of study designs, risk factors and outcomes 
restrict our result to only a systematic review and precluded 
a formal meta-analysis.
Case-control studies
Three case-control studies were included (Pouw et al 2000; 
Garcia-Aymerich et al 2001; Bourbeau et al 2003) (Table 1). 
The risk factors that were examined in these studies were: 
low BMI on admission, weight loss during hospitalization 
(Pouw et al 2000), inhaled corticosteroids use previous 
admission (Bourbeau et al 2003), lower FEV1 and under-
prescription of LTOT (Garcia-Aymerich et al 2001). In 
two studies, there were equal numbers of case and control 
Table 1 Study Characteristics of the included studies
No.  First author, Year  Country of origin  Study design  Risk/protective factors    Outcome
1  Pouw 2000   Netherlands  C-C  Low BMI on admission,
        Weight  loss  during  Readmission
        hospitalization
2  Bourbeau 2003  Canada  C-C  Inhaled corticosteroids  Hospitalization
3  Garcia-Aymerich 2001  Spain  C-C  Previous admissions,
        lower  FEV1, LTOT  Hospitalization
4  Garcia-Aymerich 2003  Spain  P-C  Physical activity  Readmission
5  Groenwegen 2003  Netherlands  P-C  Younger Age, long term oral
        corticosteroid  Readmission
6  Kessler 1999  France  P-C   Chronic hypercapnic respiratory
        insufﬁ  ciency, pulmonary  Hospitalization
        hypertension
7  Wilkinson 2004  U.K  P-C   Early therapy  Hospitalization
8  Soler-Cataluna 2005  Spain  P-C   Older age, PaCO2 Hospitalization
9  Gudmundsson 2005   Nordic  P-C   Anxiety, low FEV1, low
        health  status  Readmission
10  Connolly 2006  U.K  P-C  Previous admission, poor
        performance  Readmission
11  Lau 2001    China  R-C  Pre hospital admission, length
          of stay >5 days,  nursing home
        residency,  self-care  activities,
          right heart strain pattern  Readmission
          on ECG, inhaled corticosteroid,
          bicarbonate level >25 mmoll–1
12  Wang 2005   Canada  R-C  Living alone, frequency of
          COPD exacerbation, not having  Readmission
        a  family  doctor
13  Garcia-Aymerich 2000  Spain  C-S  No rehabilitation, poor inhaler
        maneuvers,  no  inﬂ  uenza  Hospitalization
          vaccination, LTOT,  smoking
14  Miravitlles 2000  Spain  C-S  FEV1 impairment, signiﬁ  cant
        comorbidity  Hospitalization
15  Cao 2006    Singapore  C-S  Disease duration >5 yrs, FEV1 
          < 50% predicted, use of psychotropic  Readmission
        drugs,  vaccination  status
16  Miravitlles 2006   Spain  C-S  Use of LTOT, increasing the
        number  of  previous
          exacerbations, short acting beta-2  Hospitalization
        agonists,  incomplete  primary
          education, impairment in health
        status
17  Gadoury 2005  Canada  RCT  Sex (female), increased walking
          distance, higher education, older  Hospitalization
          age, reduced health status
R-C = retrospective-cohort, P-C = prospective-cohort, C-S = cross–sectional, C-C = case–control, RCT = randomised control trialInternational Journal of COPD 2007:2(3) 244
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subjects (Pouw et al 2000; Garcia-Aymerich et al 2001). 
Quality of reporting of case-control studies was evaluated 
using four questions including whether: exposure assess-
ment was the same for cases and controls; exposure asses-
sors were blind to case-control status; cases and controls 
were from the same population; and whether the number of 
and reasons for study withdrawals were reported (Table 3) 
(Pouw et al 2000). Exposure assessments of cases and con-
trols were assessed to be similar in all three studies (Pouw 
et al 2000; Garcia-Aymerich et al 2001; Bourbeau et al 
2003). As there was no explicit mention whether exposure 
assessors were blinded or not, we considered them as not 
blinded. Controls were assessed by the reviewers to be 
from the same population as the cases in all three studies. 
Information on withdrawals was reported only in one study 
(Garcia-Aymerich et al 2001) while in the other study it was 
partially reported (Pouw et al 2000). Again; these results 
suggest that there is a risk of bias, particularly interviewer 
bias, in these studies.
Cohort studies
There were 9 cohort studies included in the review 
(Table 1), (Kessler et al 1999; Lau et al 2001; Garcia-Aymerich 
et al 2003; Groenewegen et al 2003; Wilkinson et al 2004; 
Soler-Cataluña et al 2005; Wang et al 2005; Gudmundsson 
et al 2005 and Connolly et al 2006). The risk factors that 
were examined were physical activity, long term oral corti-
costeroid use, age, chronic hypercapnic respiratory failure, 
Table 2 Demographic characteristics of the included studies
Study design/First  Sample size  Age  Gender
author/year (n)  (years)  Male  (%)
Case-control    Case Control  Case Control  Case Control
Pouw 2000  14  14  71 (9)  69 (5)  57  57
Bourbeau 2003  843  11030  76 (8)  76 (7)  66  62
Garcia-Aymerich 2001  86  86  70 (8)  69 (9)  91  91
Cohort/cross sectional
Garcia–Aymerich 2003  340  69 (9)  92
Lau 2001  551  74 (9)  77
Soler-Cataluna 2006  304  71 (9)  100
Wilkinson 2004  128  67 (7)  69
Kessler 1999  64  64 (9)  84
Groenwegen 2003  171  71 (9)  61
Garcia-Aymerich 2000  353  69 (9)  92
Miravitlles 2000   1001  70 (10)  89
Cao 2006  186  75 (25)  83
Miravitlles 2006  1057  67 (9)  95
Wang 2005  54  71 (10)  61
Gudmundsson 2005  406  69 (11)  49
Connolly 2006  7514  71(10)  52
RCT Intervention  usual  Intervention  usual  Intervention  usual
Gadoury 2005  96  95  69 (7)  70 (7)  52  59
Age: Mean (SD)
Table 3 A quality scoring system for case-control studies
First author  Was exposure  Were exposure  Were cases and  Were the number
  assessment the  assessors blind to  controls from the  and reasons for
  same for cases  case-control status?  same population?  study withdrawals
 and  controls?      reported?
  Yes (2), Partial (1),  Yes (2), Partial (1),  Yes (2), Partial (1),  Yes (2), Partial (1),
  No (0)  No (0)  No (0)  No (0)
Pouw  2000  2 0 2  1
Bourbeau  2003  2 0 2  0
Garcia-Aymerich  2001  2 0 2  2International Journal of COPD 2007:2(3) 245
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pulmonary hypertension, early therapy, hospital admission 
within 1 year before index admission, poor performance sta-
tus, total length of stay in index admission >5 days, nursing 
home residency, dependency in self-care activities, right heart 
strain pattern on electrocardiogram, on high dose inhaled 
corticosteroid, actual bicarbonate level >25mmol, frequency 
of COPD exacerbation, living alone, not having a family 
doctor, anxiety, low FEV1 and low health status.
Quality of reporting of cohort studies was evaluated 
using ﬁ  ve questions assessing whether: the studies were 
prospective or retrospective cohort; exposure assessment 
was the same for all participants; outcome assessment was 
the same for all participants; outcome assessors were blind 
to exposure status; and whether the number of and reasons 
for study withdrawals were reported (MacKay et al 2003).
The score for each question is reported in Table 4. We used 
the median of the scores to categorize the quality of studies. 
Based on the median 7, studies that scored seven or more 
were considered good (Kessler et al 1999; Garcia-Aymerich 
et al 2003; Groenewegen et al 2003; Wilkinson et al 2004; 
Soler-Cataluña et al 2005; Gudmundsson et al 2005; Connolly 
et al 2006) and less than seven were considered poor quality 
(Lau et al 2001 and Wang et al 2005).
Cross sectional studies
Four cross sectional studies were included in the review 
(Garcia-Aymeric et al 2000; Miravitlles et al (2000, 2006); 
Cao et al 2006). The risk factors that were examined in these 
studies were: no rehabilitation, poor inhaler maneuvers, no 
inﬂ  uenza vaccination, under prescription of LTOT, smok-
ing, FEV1 impairment and signiﬁ  cant comorbidity, disease 
duration >5 yrs, use of psychotropic drugs, the increasing 
number of previous exacerbations, short acting beta-2 
agonists, incomplete primary education and health status 
impairment. No quality assessment of the cross sectional 
studies were reported in this review.
Randomized control trial
Only one RCT was included in this review (Gadoury et al 
2005). The predictive factors of reduced hospitalization for 
the intervention (self-management) group in this study were 
sex (female), increased walking distance and higher educa-
tion and risk factors of increased hospitalizations were older 
age and reduced health status.
The quality of this trial was assessed using standard 
criteria (allocation concealment, blinding, analysis by inten-
tion to treat, and completeness of follow-up) based on Jadad’s 
quality scale (Jadad et al 1996).
Risk factors for COPD exacerbation 
resulting in admission/readmission to 
hospital
Among the many risk factors studied in this review, PaCO2 
was reported by most studies (52%) (Kessler et al 1999; 
Garcia-Aymerich et al 2001; Lau et al 2001; Groenewegen 
et al 2003; Soler-Cataluña et al 2005). Of these, one was 
case-control study (Garcia-Aymerich et al 2001) and four 
were cohort studies (Kessler et al 1999; Lau et al 2001; 
Groenewegen et al 2003; Soler-Cataluña et al 2005).
Increased PaCO2 has proved to be an independent predic-
tive factor of early hospital admission in two studies (Kessler 
Table 4 A quality scoring system for cohort studies
First author  P (2),  Was exposure  Was outcome  Were outcome  Were the number of 
  R (1)  assessment the  assessment the  assessors blind  and reasons for study
    same for all  same for all  to exposure  withdrawals
   participants?  participants?  status?  reported?
    Yes (2),  Yes (2),  Yes (2),  Yes (2),
    Partial (1),  Partial (1),  Partial (1),  Partial (1),
    No (0)  No (0)  No (0)  No (0)
Lau  2001  1  1 2 1 1
Kessler  1999  2  1 2 1 2
Wilkinson  2004  2  1 2 1 2
Garcia-Aymerich  2003  2  2 2 1 2
Groenwegn  2003  2  1 2 1 2
Soler  2005  2  2 0 1 2
Wang  2005  1  1 1 0 2
Gudmundsson  2005  2  1 1 1 2
Connolly  2006  2  1 1 2 1
R = retrospective, P = prospectiveInternational Journal of COPD 2007:2(3) 246
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et al 1999 and Lau et al 2001) and it has shown to be predic-
tive of reduced survival in another study (Soler-Cataluña et al 
2005). One study also reported PaCO2 to be signiﬁ  cant in the 
univariate analysis, (p value 0.025) (OR 1.04, 95% conﬁ  dence 
interval [CI] 1.01 to1.08) for hospitalization following an 
exacerbation of COPD (Garcia-Aymerich et al 2001). But it 
was not found to be a risk factor for hospital readmission in 
another prospective study (Groenewegen et al 2003).
Lower FEV1 was associated with higher risk of COPD 
readmission in four studies (Garcia-Aymerich et al (2001, 
2003); Gudmundsson et al 2005; Cao et al 2006). The result 
of a study by Miravitlles et al (2000), suggest that FEV1 im-
pairment explains part of the risk of frequent exacerbations 
and hospital admissions. Three other studies also looked at 
FEV1% predicted at time of admission; however they did not 
ﬁ  nd this to be a signiﬁ  cant risk factor (Kessler et al 1999; 
Garcia-Aymerich et al 2000; Groenewegen et al 2003).
Both oral and inhaled corticosteroids were studied as 
risk factors for COPD exacerbations (Garcia-Aymerich et al 
(2001, 2003); Lau et al 2001; Bourbeau et al 2003). Inhaled 
corticosteroid was a signiﬁ  cant risk factor for early hospital 
admission in both univariate and multivariate analysis in a 
study by Lau et al (2001). The results from this study supports 
the previous trial by Burge et al (2000), however no appar-
ent inﬂ  uence from inhaled corticosteroids was found, even 
at moderate to high doses, on the likelihood of a subsequent 
hospitalization for COPD exacerbation in two case control 
studies (Garcia-Aymerich et al 2001; Bourbeau et al 2003).
Use of high dose oral corticosteroid was associated 
with a significantly increased risk of readmission in a 
cross sectional study at p value 0.006 with the (OR 1.55, 
95% confidence interval [CI] 1.13 to 2.11) (Garcia-
Aymerich et al 2003). High dose systematic corticosteroid 
was reported as a significant factor for shorter time to 
readmission in the univariate analysis of a retrospective 
study (Lau et al 2001), and its long term use was reported 
as a risk factor of hospital readmission in a prospective 
cohort study (Groenewegen et al 2003). Oral corticoste-
roid was related to a higher risk of admission in the crude 
analysis of a case control study (Garcia-Aymerich et al 
2001) but its lack of association in the adjusted model 
was interpreted as a marker of disease severity.
In a study by Garcia-Aymerich et al (2003) two variables: 
the highest tertile of usual physical activity and a higher score 
of physical quality of life showed a statistically signiﬁ  cant 
reduced risk of readmission.
In another study by Garcia-Aymerich et al (2001) physical 
scale of health related quality of life was related to COPD 
admission in the crude analysis as in two previous studies 
(Keistinen et al 1996; Seemungal et al 1998) and maintained 
an association (although non signiﬁ  cant) in the clinical model 
adjusted analysis. But this relationship after including dys-
pnea in this model was lost, indicating that physical quality 
of life and admission was confounded by dyspnea.
Dependency for assistance in self-care activities was 
shown to be an independent risk factor for shorter time to 
readmission in a retrospective study (Lau et al 2001). Both 
active and passive smoking was reported by some studies 
(Kessler et al 1999; Garcia-Aymerich et al (2000, 2001, 
2003); Miravitlles et al 2000) to be risk factors. One cross sec-
tional study reported that being a former smoker exposed to 
passive smoking was associated with a signiﬁ  cantly increased 
risk of readmission (Garcia-Aymerich et al 2003).
In a multivariate logistic regression of a case-control 
study, current smoking was found to be a protective factor 
against COPD hospitalization (OR 0.30, p value 0.0222) 
(Garcia-Aymerich et al 2001). However in two studies 
no association was found between current smoking and 
hospital admission (Kessler et al 1999, Miravitlles et al 
2000). Long Term use of Oxygen Therapy (LTOT) was 
reported as a risk factor in ﬁ  ve studies (Kessler et al 1999; 
Lau et al 2001; Garcia-Aymerich et al (2001, 2003); Wang 
et al 2005).
Lau et al (2001) reported that LTOT was associated with a 
shorter time to readmission (P < 0.0001). Three other studies 
reported that LTOT signiﬁ  cantly increased the risk of hos-
pitalization for acute exacerbations of COPD (Kessler et al 
1999; Garcia-Aymerich 2001 et al; Wang et al 2005).
LTOT was also associated with a higher risk of readmission 
for COPD in a study by Garcia-Aymerich, but this did not reach 
statistical signiﬁ  cance (Garcia-Aymerich et al 2003).
In Garcia-Aymerich et al’s (2001) study, low body 
mass index (BMI) was associated with admission only in 
the univariate analysis. This was in agreement with another 
study conducted by Kessler et al (1999). BMI on admission 
along with weight change during hospitalization were both 
signiﬁ  cantly associated with unplanned early readmission 
in a study by Pouw et al (2000). While in three other stud-
ies there were no signiﬁ  cant association between BMI and 
hospital readmission (Miravitlles et al 2000; Groenewegen 
et al 2003; Cao et al 2006).
Total length of stay in the index admission of more than 
5 days and nursing home residency were the other signiﬁ  cant 
risk factors for early readmission reported by Lau et al. (2001). 
This study also reported that hospital admission within one 
year before the index admission was a signiﬁ  cant risk factor International Journal of COPD 2007:2(3) 247
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for re admission (p < 0.0001). Similarly having more than 
three COPD admissions in the year before recruitment was 
found to be associated with an increased risk of readmission, 
in two studies by Garcia-Aymerich et al (2001, 2003) and a 
recent study by Connolly et al (2006). In contrast to these 
ﬁ  ndings, no association was found between the number of 
previous hospital admissions and unplanned early readmis-
sion in a retrospective study by Pouw et al (2000).
Patients with a longer history of having a COPD diagnosis 
(more than 5 years) were found to be approximately twice as 
likely to have frequent readmissions than those with a shorter 
duration (OR = 2.51, 95% conﬁ  dence interval [CI] 1.39 to 
4.53) (Cao et al 2006).
Co-morbid conditions such as right heart strain on ECG, 
coronary artery disease, left ventricular failure, diabetes 
mellitus, were also found to be signiﬁ  cant risk factors for 
admission in the same study (Lau et al 2001) as well as 
in another cross sectional study (Miravitlles et al 2000). 
However, surprisingly the presence of comorbidity was not 
found to be signiﬁ  cantly associated with readmission in four 
other studies (Pouw et al 2000; Garcia-Aymerich et al 2003; 
Groenewegen et al 2003 and Cao et al 2006).
Older age was considered as a risk factor for hospital-
ization in two studies (Soler-Cataluña et al 2005; Gadoury 
et al 2005) but in another study was not associated with an 
increased risk (Kessler et al 1999). It was also associated with 
a shorter time to ﬁ  rst readmission after discharge in another 
study (Lau et al 2001). Age related deﬁ  ciencies in process 
of care did not predict inpatient or readmission in the recent 
high sample size study by Connolly et al (2006).
Female gender was reported as a predictive factor for 
reduced hospitalization in a multicenter, randomised con-
trolled trial (Gadoury et al 2005), but neither age nor gender 
was found to be an related to COPD admission in a study by 
Garcia-Aymerich et al (2001). Low health status was found 
to be an important risk factor for both admission and read-
mission of COPD patients who experienced an exacerbation 
(Gudmundsson 2005; Miravitlles et al 2006; Gadoury et al 
2005). In a retrospective cohort study it has been reported that 
patients with poor health related quality of life (HRQoL) had 
frequent ER visits and readmissions to hospital (Wang et al 
2005). Wilkinson et al (2004) demonstrated that patients who 
habitually fail to seek therapy for their exacerbations have 
worse HRQoL and are more likely to be hospitalized for the 
management of an exacerbation. This supports the results and 
their other study that the patients who had no family doctor 
were predisposed to readmission (OR 1.435, 95% conﬁ  dence 
interval [CI] 0.14 to1.34), p value 0.008) (Wang et al 2005).
Patients with severe dyspnea have been found to be more 
likely to be readmitted to hospital in a univariate analysis 
(OR = 1.87, 95% conﬁ  dence interval [CI] 0.98 to 3.28) (Cao 
et al 2006).This supports the results of a retrospective cohort 
study that patients with severe dyspnea and frequent COPD 
exacerbations had frequent emergency visits and readmis-
sions to hospital (Wang et al 2005). In an earlier study it 
has been shown that patients with dyspnea of grade 2 never 
experienced hospital admissions for acute exacerbation, but 
with a dyspnea of grade 3, 4 or 5 they had a signiﬁ  cant risk 
of hospitalization at one year (Kessler et al 1999).
Characteristics of the risk or protective factors included 
in this review are shown in Appendix 1.
Discussion
This systematic review evaluated the results of 17 studies for 
risk factors for admission or readmission in COPD patients 
who had experienced an exacerbation. Variables including 
using long term oxygen therapy, having low health status 
or poor health related quality of life and not having routine 
physical activity were all associated with an increased risk 
of admission and readmission to hospital.
PaCO2 was shown to be an independent risk factor for 
hospital admission for an acute exacerbation of COPD. 
Higher levels of PaCO2 likely represents a marker of disease 
severity or less likely that patients with chronic hypercapnia, 
and hence raised actual bicarbonate, are probably more eas-
ily symptomatic than normocapnic patients because of their 
rapid and shallow breathing pattern (Ringbaek et al 2002), 
resulting in earlier and more frequent need for acute care.
In this review, three predictive factors: “previous hospital 
admission”, “dyspnea” and “oral corticosteroids” were all 
found to be signiﬁ  cant risk factors of readmissions. Oral 
corticosteroids are often used in the treatment of acute ex-
acerbations of COPD. In contrast, studies of the utility of 
inhaled corticosteroids in COPD patients who require hos-
pital admission or emergency department treatment provide 
conﬂ  icting results, with some studies reporting improvement 
and others reporting no effect. This inconsistency suggests 
that the results of ongoing clinical trials, designed to look at 
the speciﬁ  cally possible beneﬁ  ts of inhaled corticosteroids 
on the risk of exacerbation, should be awaited before rec-
ommending their routine use in COPD patients. The most 
recent such study, paradoxically showed an increased risk of 
pneumonia in patients with COPD (Calverley et al 2007).
In some studies use of long-term home of supplemental 
oxygen (LTOT) was independently associated with 
admission or shorter time to ﬁ  rst readmission for acute International Journal of COPD 2007:2(3) 248
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exacerbations of COPD. However in other studies, this 
association was not signiﬁ  cant or it did not remain signiﬁ  cant 
after adjustment, indicating that LTOT could be probably a 
marker of severity in those patients.
The negative association between current smoking and 
hospital admission was explained by Anthonisen (2000) in 
that many severely ill patients with COPD spontaneously 
quit smoking in response to their symptoms and disability, 
and it is hardly surprising that these patients do not do well 
afterwards. For this reason studies of patients with well estab-
lished disease have often not shown a reduction in admission 
with smoking cessation.
Prospective studies including a wider range of COPD 
severity would be helpful to clarify this issue.
Low body mass index (BMI) was associated with admis-
sion and non elective readmission and consistently with its 
relation to prognosis of COPD in three studies (Kessler et al 
1999; Pouw et al 2000; Garcia-Aymerich et al 2001). It is 
not clear whether the observed relationships between both 
low body weight on admission and early readmission are 
causal relationships or whether these parameters represent 
epiphenomena of more severe disease. There is a hypothesis 
that tissue depletion in patients with COPD may be related 
in part to a systemic catabolic response induced by inﬂ  am-
mation, which cannot completely be reversed by nutritional 
support only (Schols et al 1998). Further studies are indicated 
to conﬁ  rm this hypothesis.
In this review, the presence of coexisting comorbidites 
was not associated with an increased probability of frequent 
exacerbations, but with an increased risk of admission. This 
suggests that comorbidity does not appear to be a risk fac-
tor for frequent exacerbations, but a risk factor for severe 
life threatening exacerbations that can provoke admission. 
We believe that potentially all co-morbidities are important 
contributing factors to COPD morbidity, and special attention 
should be paid to the diagnosis of coexisting disease and its 
association with COPD admission.
Patients with COPD who perform a relatively high level 
of physical activity in their daily life have been shown a 
substantially reduced risk of readmission due to exacerbation 
(Garcia-Aymerich et al 2001; Lau et al 2001).The explana-
tion could be that exercise engages cardiovascular system 
and helps the body to deliver oxygen to respiratory muscles 
more efﬁ  ciently. In addition, endurance training can reduce 
exercise induced lactic acidosis and improve the oxidative 
capacity of the muscles in patients with moderate to severe 
COPD. Therefore such muscles would be more able to toler-
ate a COPD exacerbation than untrained muscles.
Longer length of stay, nursing home residents (Lau et al 
2001), taking anticholinergics (Garcia-Aymerich et al 2003), 
increasing age and chronic mucus hypersecretion (CMH) 
(Miravitlles et al 2000), were the other factors associated 
with early readmission.
Being managed by a respirologist was also associated 
with higher risk of readmission, contrary to what might 
have been expected, and it was not totally removed after 
adjustment for previous admission, suggesting that other 
mechanisms may be operating. However, in another study 
(Wilkinson et al 2004), it has been demonstrated that 
prompt treatment by a physician is associated with better 
outcomes.
Older age was associated with shorter time to first 
readmission and increased risk of hospitalization in several 
studies (Lau et al 2001; Soler-Cataluña et al 2005; Gadoury 
et al 2005). This may be related to the higher degree of dis-
ability and comorbidity in the older population.
Patients who habitually fail to seek therapy for their 
exacerbations have worse health-related quality of life 
and are more likely to be hospitalized for the manage-
ment of an exacerbation. Patients with more symptoms at 
exacerbation onset tended to present earlier for treatment, 
and those exacerbations with more symptoms were indeed 
more severe, as they took longer to recover. Therefore, 
the milder and less symptomatic exacerbations were in 
fact presenting slightly later, and when this effect is taken 
into account, the benefit of early treatment became more 
pronounced.
In conclusion, our results for this systematic review 
suggest that there are a number of potential modiﬁ  able fac-
tors that are independently associated with the higher risk 
of COPD exacerbation requiring admission/readmission to 
hospital. Identifying these factors and the development of 
targeted interventions could potentially reduce the number 
and severity of such exacerbations.
Limitations of our study
We reviewed only published studies, and unpublished stud-
ies may contain valid results that conﬂ  ict with our conclu-
sions. This is of particular concern in a systematic review of 
observational studies as there is a greater tendency towards 
publication bias than there is with randomised controlled 
trials (Easterbrook et al 1991).
We did not search the gray literature (ie, literature that 
is difﬁ  cult to identify, locate and retrieve, examples would 
include theses, proceedings of workshops etc) extensively.
We included only English language papers and since in this International Journal of COPD 2007:2(3) 249
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review most of the articles were studied and published in 
Europe, we might have missed some non-English related 
articles and also we may have overestimated the method-
ological limitations of the included studies because we relied 
on published reports.
There is a chance that we may have missed other studies 
because of these limitations, but considering the broad nature 
of our search strategy and the number of citations screened, 
we believe this risk to be small. In addition, the included 
studies may have suffered from other design weaknesses such 
as confounding by variables other than sample size problems, 
which we did not address. Our challenge in categorizing study 
design and assigning primary outcomes certainly suggest that 
design was an issue. To avoid selection bias, a systematic 
and comprehensive search was conducted and two reviewers 
independently evaluated trials for inclusion. Because of the 
wide variation in end points and study design we were not 
able to do a formal meta analysis.
Implications for policy makers 
and future research
The evidence related to hospital admission and readmission 
is currently equivocal and requires further study. Several 
potentially important outcomes including patients’ satis-
faction, self management, patients’ coping and adherence, 
smoking cessation, and the effects on social function have 
not been fully evaluated. There is also a need to evaluate 
the economic implications of COPD exacerbations and 
especially hospitalizations.
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Appendix 1
Characteristics of the risk/protective factors studied in this systematic review
Risk/Protective First  author  No.  of Crude  P-value  Adjusted Adjusted  Outcome*
Factors   patients  HR/OR/RR    HR/OR/RR  p-value  A,R,E
     (95%CI)    (95%CI)
Hospital Garcia-Aymerich  2003  340  2.27  (1.69–3.04)  0.000  –  – R
admission in  Garcia-Aymerich 2001  172  3.82 (1.14–2.75)  0.030  6.21 (1.60–24.07)  0.008  A
the previous Lau  2001  551  1.55  (1.22–1.98)  <0.001  –  –  R
year Gudmundsson  2005  416  1.98  (1.42–2.76)  –  –  -  R
  Connolly  2006 7514  –  – –  – R
PCO2 Garcia-Aymerich  2001  172  1.04  (1.01–1.08)  0.025  –  –  A
 Lau  2001  551  –  0.007  –  –  R
 Kessler  1999  64  2.1  (1.4–3.1)  0.0003  –  –  A
FEV1 Pred%  Garcia-Aymerich 2001  172  0.97 (0.95–0.99)  0.002  0.96 (0.93–0.98)  0.000  A
  Garcia-Aymerich 2003  340  0.97 (0.96–0.98)  0.000  0.97 (0.96–0.99)  0.001  R
  Miravitlles 2000  713  –  –0.72 (0.58–0.88)  –  A
 Cao  2006  186  2.60  (1.18–5.74)  0.018  –  –  R
 Wang  2005  54  2.08  (0.01–0.77)  0.003  –  –  E
 Gudmundsson  2005  416  0.83  (0.76–0.91)  –  –  –  R
LTOT Garcia-Aymerich  2001  172  –  –  22.6  (2.31–21.88)  0.007  A
  Garcia-Aymerich 2003  340  2.36 (1.79–3.11)  0.000  1.26 (0.87–2.05)  0.223  R
 Lau  2001  551  –  <0.0001  –  –  A
 Miravittles  2006  1057  3.47  (2.35–5.12)  <0.0001  –  –  A
 Wang  2005  54  4.85  (1.33–17.75)  0.014  –  –  E
Health status Miravittles  2006  1057  1.01  (1.00–1.02)  0.0008  –  –  A
impairment
Comorbidity Lau  2001  551  1.56  (1.19–2.04)  0.001  –  –  R
 Miravitlles  2006  713  –  –  1.97  (1.24–3.14)  –  A
 Wang  2005  54  0.66  (0.45–0.96)  0.031  –  –  E
Oral  Garcia-Aymerich 2003  340  1.55 (1.13–2.11)  0.006  1.59 (1.07–2.37)  0.021  R
corticosteroids Groenwegen  2003  171  –  0.0026  –  –  R
 Lau  2001  551  –  0.0151  –  –  R
Inhaled Lau  2001  551  1.35  (1.02–1.80)  0.036  –  –  R
corticosteroid Miravittles  2006  1057  –  <0.0001 –  –  A
BMI Pouw  2000  28  –  0.046  –  –  R
 Garcia-Aymerich  2001  172  0.92  (0.86–0.99)  0.023  –  –  A
 Kessler  1999  64  –  0.015  –  –  A
Current  Garcia-Aymerich 2001  172  0.46 (0.20–1.01)  0.053  0.45 (0.19–1.05)  0.063  A
smoking Gudmundsson  2005  416  0.78  (0.55–1.10)  – –  – R
Older age Lau  2001  551 –  0.0013  –  –  R
 Soler-Cataluna  2006  304  –  –  4.52  (2.31–8.83)  <0.001  A
 Wang  2005  54  0.91  (0.85–0.97)  0.0028  –  –  E
 Gadoury  2005  191  –  –  1.05  (1.03–1.06)  –  E
Living alone Miravitlles  2006  1057  –  0.007 –  –  A
 Wang  2005  54  0.60  (0.00–0.82)  0.0092  –  –  R
Physical  Garcia-Aymerich 2001  172  0.96 (0.93–0.99)  0.02  0.97 (0.94–1.01)  0.104  A
activity/Scale Lau  2001  551  1.40  (1.06–1.83)  0.0001 –  –  R
Health related  Garcia-Aymerich 2003  340  0.46 (0.32–0.68)  0.000  0.49 (0.31–0.79)  0.003  R
QoL*      0.97  (0.95–0.98)  0.000 0.98  (0.96–0.99)  0.007 R
Dyspnea Cao  2006  186  1.80  (0.98–3.28)  <0.05  –  –  R
Family doctor Wang  2005  54  1.44  (0.14–1.34)  0.008  –  –  R
     4.06  (1.06–10.51)  0.041  –  –  E
Pulmonologist  Garcia-Aymerich 2003  340  2.16 (1.43–3.27)  0.000  1.77 (1.07–2.92)  0.025  R
Inﬂ  uenza Cao  2006  186  8.14  (1.77–37.47)  0.002  –  –  R
vaccination
* Outcome: A= Admission; R= Readmission, E= Exacerbation, QoL= Quality of Life